Announcements Trials
Browse Landscape

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 81Observational 4Expanded_access 1

Sponsor

Cancer Type

Gynecologic 4

Conditions

Ovarian Neoplasms 2Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Advanced Ovarian Cancer 1

Interventions

Blood Specimen Collection 135Surveys and Questionnaires 132Specimen Handling 57Observation 55Radiotherapy 43Interviews as Topic 35Surgical Procedures, Operative 31Biopsy 30Drug Therapy 30Data Collection 25Magnetic Resonance Spectroscopy 25Nivolumab 21Immune Checkpoint Inhibitors 18Watchful Waiting 18Standard of Care 17Therapeutics 17Immunotherapy 16Magnetic Resonance Imaging 16trastuzumab deruxtecan 14Liquid Biopsy 13Restraint, Physical 13Tomography, X-Ray Computed 13palbociclib 13Radiosurgery 12enzalutamide 12Focus Groups 11Hematologic Tests 11apalutamide 11darolutamide 11pembrolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × niraparib × 1 year × Clear all
NCT04295577 2026-05-13

MONITOR-UK

Royal Marsden NHS Foundation Trust

Completed
388 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05021562 2026-04-13

A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice

Takeda

Completed
354 enrolled
Gynecologic

Ovarian Neoplasms

NCT06086665 2026-02-04

REFIRM

Asan Medical Center

Completed
850 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT07059676 2025-07-11

LIBINI-1

Clinica Universidad de Navarra, Universidad de Navarra

Not yet recruiting
120 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡